GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Carasent ASA (OSL:CARA) » Definitions » EV-to-EBIT

Carasent ASA (OSL:CARA) EV-to-EBIT : -21.17 (As of May. 30, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Carasent ASA EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Carasent ASA's Enterprise Value is kr980.3 Mil. Carasent ASA's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr-46.3 Mil. Therefore, Carasent ASA's EV-to-EBIT for today is -21.17.

The historical rank and industry rank for Carasent ASA's EV-to-EBIT or its related term are showing as below:

OSL:CARA' s EV-to-EBIT Range Over the Past 10 Years
Min: -1379.84   Med: 0.5   Max: 622.53
Current: -21.17

During the past 13 years, the highest EV-to-EBIT of Carasent ASA was 622.53. The lowest was -1379.84. And the median was 0.50.

OSL:CARA's EV-to-EBIT is ranked worse than
100% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 17.81 vs OSL:CARA: -21.17

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Carasent ASA's Enterprise Value for the quarter that ended in Mar. 2024 was kr508.0 Mil. Carasent ASA's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr-46.3 Mil. Carasent ASA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -9.11%.


Carasent ASA EV-to-EBIT Historical Data

The historical data trend for Carasent ASA's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carasent ASA EV-to-EBIT Chart

Carasent ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 90.84 -53.38 475.28 19.80 -9.97

Carasent ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -173.71 -33.61 -13.41 -9.97 -10.97

Competitive Comparison of Carasent ASA's EV-to-EBIT

For the Health Information Services subindustry, Carasent ASA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carasent ASA's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Carasent ASA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Carasent ASA's EV-to-EBIT falls into.



Carasent ASA EV-to-EBIT Calculation

Carasent ASA's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=980.310/-46.305
=-21.17

Carasent ASA's current Enterprise Value is kr980.3 Mil.
Carasent ASA's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-46.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carasent ASA  (OSL:CARA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Carasent ASA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-46.305/508.029696
=-9.11 %

Carasent ASA's Enterprise Value for the quarter that ended in Mar. 2024 was kr508.0 Mil.
Carasent ASA's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-46.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carasent ASA EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Carasent ASA's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Carasent ASA (OSL:CARA) Business Description

Traded in Other Exchanges
Address
Ovre Slottsgate 2B, Oslo, NOR, 0157
Carasent ASA is an investment management company that provides services to businesses that develop entrepreneurial and e-health solutions. The company has a system called 'Webdoc' a cloud-based medical record system with integrated add-on services for the private and public health care industry.

Carasent ASA (OSL:CARA) Headlines